IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 42 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $22,000 | +69.2% | 6 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | -93.3% | 6 | -94.5% | 0.00% | – |
| Q2 2020 | $195,000 | +35.4% | 109 | 0.0% | 0.00% | – |
| Q1 2020 | $144,000 | -27.3% | 109 | 0.0% | 0.00% | – |
| Q4 2019 | $198,000 | -97.2% | 109 | -95.5% | 0.00% | – |
| Q3 2019 | $6,982,000 | +8.2% | 2,416 | 0.0% | 0.00% | – |
| Q2 2019 | $6,451,000 | -40.5% | 2,416 | -43.2% | 0.00% | – |
| Q1 2019 | $10,850,000 | +1729.7% | 4,255 | +1888.3% | 0.00% | – |
| Q4 2018 | $593,000 | -86.7% | 214 | -57.2% | 0.00% | – |
| Q3 2018 | $4,455,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |